Technologies that could offer a step change in treatment or management of incontinence were the focus of the latest symposium, run by the IMPRESS network.
The event, on June 20, attracted delegates from industry, academia and clinical practice as well as patients, keen to hear about and discuss next generation technologies.
The day opened with a welcome from HTC engineering lead and IMPRESS principal investigator, Dr Peter Culmer, and a keynote address from the highly regarded incontinence researcher, Professor Alan Cottenden, from University College London.
Delegates then heard about new technologies being developed in the Netherlands, Switzerland and by various groups in the UK. Researchers from ETH Zurich presented the latest on their work to develop a stretchable, highly conductive silicon material, that could be patched onto the bladder to act as a sensor indicating how full it is. The Dutch start-up company, Novuqare BV, demonstrated their electrical stimulation device – already on the market – which helps people to retrain their pelvic floor muscles. UK presentations from the University of York and Queens University Belfast included re-engineered bladder tissue and antimicrobial catheter coatings.
HTC Engineering Lead, Dr Culmer, said: “There was a really broad range of talks, showing how technologies from many different disciplines can and are being applied to this important challenge. With plenty of opportunities for networking as well, we hope the day inspired new ideas and look forward to receiving some interesting applications to our next round of funding.”
For more details on the IMPRESS plus funding call, see: http://www.impress-network.com/page/impressplus-funding-call